Johnson & Johnson JNJ
$276.22 +$3.90 (+1.43%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $276.00 -0.08%
Open$267.56
Prev close$272.32
Day range$265.55 – $276.41
Volume8.86M
Market cap$664.95B
P/E (TTM)42.0
Dividend yield1.91%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$25.40B+5.9% YoY
Operating profit$6.37B-10.3% YoY
Net profit$210.00M-95.9% YoY
Diluted EPS$0.09-95.9% YoY
Free cash flow$5.36B-32.9% YoY
Operating cash flow$7.72B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin67.6%
Operating margin25.7%
Net margin16.2%
Liabilities / assets58.7%
Cash & investments$17.23B
Total debt$44.65B
Net cash (debt)-$27.42B
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL |
|---|---|---|---|---|---|
| Total Revenue as Reported | $25.40B | $25.40B | $25.31B | $24.06B | $94.19B |
| Total Operating Revenue | $25.40B | $25.40B | $25.31B | $24.06B | $94.19B |
| Cost of Revenue | $8.10B | $8.10B | $8.05B | $8.11B | $30.26B |
| Gross Profit | $17.30B | $17.30B | $17.26B | $15.96B | $63.94B |
| Operating Expense | $10.94B | $10.94B | $10.09B | $9.56B | $38.34B |
| Selling and Admin Expenses | $6.29B | $6.29B | $6.43B | $6.03B | $23.68B |
| Research & Development | $4.65B | $4.65B | $3.65B | $3.53B | $14.67B |
| Operating Profit | $6.37B | $6.37B | $7.17B | $6.40B | $25.60B |
| Net Non-Operating Interest Income (Expense) | -$31.00M | -$31.00M | -$62.00M | -$43.00M | $85.00M |
| Total Other Finance Costs | $31.00M | – | – | – | – |
| Other Income (Expense) | -$6.30B | -$6.32B | -$365.00M | -$362.00M | $6.89B |
| Special Income (Charges) | -$520.00M | -$6.62B | -$34.00M | -$468.00M | $5.49B |
| -Less:Restructuring and Mergern & Acquisition | $181.00M | $181.00M | $34.00M | $132.00M | $428.00M |
| -Less:Impairment of Capital Assets | $339.00M | – | – | – | $81.00M |
| Other Non-Operating Income (Expenses) | -$5.78B | $300.00M | -$331.00M | $106.00M | $1.00B |
| Pretax Profit | $34.00M | $34.00M | $6.75B | $5.99B | $32.58B |
| Tax | -$176.00M | -$176.00M | $1.21B | $755.00M | $5.78B |
| Net Profit | $210.00M | $210.00M | $5.53B | $5.24B | $26.80B |
| Profit from Continuing Operations | $210.00M | $210.00M | $5.53B | $5.24B | $26.80B |
| Net Income to Parent Company | $210.00M | $210.00M | $5.53B | $5.24B | $26.80B |
| Net Income to Common Stockholders | $210.00M | $210.00M | $5.53B | $5.24B | $26.80B |
| Basic EPS | $0.09 | $0.09 | $2.30 | $2.17 | $11.13 |
| Diluted EPS | $0.09 | $0.09 | $2.27 | $2.14 | $11.03 |
| Dividend Per Share | $1.34 | $1.34 | $1.34 | $1.30 | $5.14 |
| Non-Operating Interest Income | – | $186.00M | $219.00M | $229.00M | $1.06B |
| Non-Operating Interest Expense | – | $217.00M | $281.00M | $272.00M | $971.00M |
| -Less:Other Special Charges | – | $6.10B | – | $300.00M | -$6.00B |
| -Less:Write Off | – | $339.00M | – | $36.00M | – |
| Gain on Sale of Security | – | – | – | – | $400.00M |
| Net Income from Discontinuous Operations | – | – | – | – | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $197.43B | $201.06B | $200.89B | $199.21B | $199.21B |
| Total Current Assets | $56.35B | $59.77B | $59.17B | $55.62B | $55.62B |
| Cash and Cash Equivalents & Short-Term Investments | $17.23B | $20.76B | $22.05B | $20.10B | $20.10B |
| -Cash and Cash Equivalents | $16.91B | $20.42B | $21.69B | $19.71B | $19.71B |
| -Short Term Investments | $318.00M | $336.00M | $363.00M | $393.00M | $393.00M |
| Receivables | $18.99B | $19.05B | $22.54B | $21.33B | $21.33B |
| -Accounts Receivable | $18.99B | $19.05B | $17.72B | $17.18B | $17.18B |
| Inventory | $15.38B | $15.14B | $14.58B | $14.19B | $14.19B |
| Other Current Assets | $4.76B | $4.83B | – | – | – |
| Total Non-Current Assets | $141.07B | $141.29B | $141.72B | $143.59B | $143.59B |
| Net PPE | $24.10B | $23.58B | $23.27B | $23.17B | $23.17B |
| -Gross PPE | $55.47B | $55.52B | $54.70B | $54.36B | $54.36B |
| -Accumulated Depreciation | -$31.37B | -$31.94B | -$31.43B | -$31.20B | -$31.20B |
| Goodwill and Other Intangible Assets | $95.13B | $96.71B | $97.62B | $99.18B | $99.18B |
| -Goodwill | $48.47B | $48.48B | $48.56B | $48.77B | $48.77B |
| -Other Intangible Assets | $46.65B | $48.23B | $49.06B | $50.40B | $50.40B |
| Non-Current Deferred Assets | $6.75B | $6.73B | $6.73B | $6.87B | $6.87B |
| Other Non-Current Assets | $15.10B | $14.27B | $14.11B | $14.37B | $14.37B |
| Total Liabilities | $115.90B | $116.09B | $119.71B | $117.67B | $117.67B |
| Total Current Liabilities | $55.46B | $54.90B | $57.72B | $54.13B | $54.13B |
| Payables | $11.29B | $10.27B | $11.55B | $13.38B | $13.38B |
| -Accounts Payable | $9.32B | $9.22B | $10.46B | $11.99B | $11.99B |
| -Total Tax Payable | $1.98B | $1.05B | $1.09B | $1.39B | $1.39B |
| Current Accrued Expenses | $31.19B | $29.45B | $25.80B | $27.72B | $27.72B |
| Short-Term Debt and Capital Lease Obligation | $8.85B | $11.69B | $17.46B | $8.50B | $8.50B |
| -Current Debt | $8.85B | $11.69B | $17.46B | $8.50B | $8.50B |
| Total Non-Current Liabilities | $60.44B | $61.20B | $61.99B | $63.54B | $63.54B |
| Long Term Accounts Payable and Other Payables | $497.00M | $485.00M | $486.00M | $486.00M | $486.00M |
| Long Term Debt and Capital Lease Obligation | $35.80B | $37.34B | $37.53B | $39.44B | $39.44B |
| -Long Term Debt | $35.80B | $37.34B | $37.53B | $39.44B | $39.44B |
| Non-Current Deferred Liabilities | $4.84B | $6.61B | $7.01B | $6.79B | $6.79B |
| Employee Benefits | $6.56B | $6.66B | $6.76B | $6.96B | $6.96B |
| Other Non-Current Liabilities | $12.75B | $10.10B | $10.21B | $9.87B | $9.87B |
| Total Equity | $81.53B | $84.97B | $81.19B | $81.54B | $81.54B |
| Stockholders' Equity | $81.53B | $84.97B | $81.19B | $81.54B | $81.54B |
| Capital Stock | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B |
| -Common Stock | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B |
| Additional Paid-In Capital | $168.36B | $171.67B | $169.16B | $168.98B | $168.98B |
| Less: Treasury Stock | $76.18B | $75.86B | $76.26B | $75.62B | $75.62B |
| Gains/Losses Not Affecting Retained Earnings | -$13.77B | -$13.95B | -$14.83B | -$14.93B | -$14.93B |
| -Other Receivables | – | – | $4.82B | $4.15B | $4.15B |
| -Preferred Stock | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $7.72B | $8.62B | $2.51B | $24.53B | $7.31B |
| Net cash flow from continuing operations | $7.72B | $8.62B | $2.51B | $24.53B | $7.31B |
| Net Income from Continuing Operations | $210.00M | $5.53B | $5.24B | $26.80B | $5.12B |
| Gain/Loss from Continuing Operations | $16.00M | -$55.00M | $12.00M | -$263.00M | -$132.00M |
| Depreciation & Depletion & Amortization | $2.12B | $1.96B | $2.00B | $7.50B | $2.01B |
| Deferred Tax | -$1.79B | -$479.00M | $159.00M | $1.54B | -$3.68B |
| Other Non-Cash Items | $962.00M | $0.00 | $2.00M | $109.00M | $0.00 |
| Change in Working Capital | $5.25B | $1.02B | -$5.23B | -$12.72B | $3.60B |
| -Change in Receivables | $188.00M | -$1.35B | -$595.00M | -$1.78B | $391.00M |
| -Change in Inventory | -$150.00M | -$571.00M | -$431.00M | -$1.45B | -$46.00M |
| -Change in Payables and Accrued Expense | $2.41B | $2.96B | -$3.92B | $2.38B | $1.27B |
| -Change in Other Current Assets | $122.00M | $950.00M | $349.00M | -$6.17B | $1.49B |
| -Change in Other Current Liabilities | $2.69B | -$972.00M | -$629.00M | -$5.70B | $499.00M |
| Net cash flow from investing | -$2.71B | -$1.11B | -$1.04B | -$23.59B | -$4.49B |
| Net Cash Flow from Continuing Investing Activities | -$2.71B | -$1.11B | -$1.04B | -$23.59B | -$4.49B |
| Net PPE Purchase and Sale | -$1.36B | -$1.32B | -$1.05B | -$4.83B | -$1.84B |
| Net Intangibles Purchase and Sale | -$995.00M | $0.00 | $0.00 | -$385.00M | $0.00 |
| Net Business Purchase and Sale | -$89.00M | – | – | -$17.54B | -$3.08B |
| Net Investment Purchase and Sale | -$253.00M | $519.00M | $65.00M | $741.00M | $2.31B |
| Net Other Investing Changes | -$10.00M | -$45.00M | -$56.00M | -$1.57B | -$1.88B |
| Financing Cash Flow | -$8.53B | -$8.78B | $530.00M | -$5.54B | -$1.37B |
| Net Cash Flow from Continuing Financing Activities | -$8.53B | -$8.78B | $530.00M | -$5.54B | -$1.37B |
| Net Issuance Payments Of Debt | -$4.36B | -$5.75B | $7.21B | $9.64B | $2.11B |
| Net Common Stock Issuance | -$1.71B | -$221.00M | -$4.03B | -$5.95B | -$1.92B |
| Cash Dividends Paid | -$3.23B | -$3.23B | -$3.13B | -$12.38B | -$3.13B |
| Proceeds from Stock Option Exercised | $743.00M | $359.00M | $1.17B | $3.42B | $1.59B |
| Net Other Financing Charges | $18.00M | $60.00M | -$697.00M | -$260.00M | -$6.00M |
| Ending Cash Balance | $16.91B | $20.42B | $21.69B | $19.71B | $19.71B |
| Net Change in Cash | -$3.52B | -$1.27B | $2.00B | -$4.60B | $1.46B |
| Beginning Cash Balance | $20.42B | $21.69B | $19.71B | $24.11B | $18.23B |
| Effect of Exchange Rate Changes | $10.00M | $5.00M | -$25.00M | $201.00M | $23.00M |
| Free Cash Flow | $5.36B | $7.30B | $1.47B | $19.31B | $5.47B |
No comments yet — be the first to weigh in on JNJ.
Sign in to join the discussion.